Alana Lelo had her original research describing STAG2 as a biomarker for bladder cancer recurrence and progression accepted for publication.
Congratulations, Alana. Our TL1 Scholar has had her paper titled "STAG2 is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle Invasive Bladder Cancer" accepted for publication as first author in the Clinical Cancer Research journal.

